What is the Projected CAGR value of the Bacterial Infectious Diseases Therapeutics Market ?
Bacterial Infectious Diseases Therapeutics Market is expected to grow at a CAGR of 8.2% during the forecast period (2024-2031).
Who are the key players in Bacterial Infectious Diseases Therapeutics Market ?
Major players are Novartis AG, GlaxoSmithkline Plc, Pfizer Inc, Merck & Co., Inc., Sanofi, Allergan, Bayer AG, AstraZeneca Plc, Bristol-Myers Squibb Company, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Johnson and Johnson, and Teva Pharmaceuticals Industries Ltd.